Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Mutagenesis and knockout models: hypothalamic-pituitary-adrenocortical system.

M E Keck1, M B Müller

  • 1Max Planck Institute of Psychiatry, Kraepelinstrasse 2-10, 80804 Munich, Germany. keck@mpipsykl.mpg.de

Handbook of Experimental Pharmacology
|April 6, 2006
PubMed
Summary

Hyperactivity in corticotropin-releasing hormone (CRH) and vasopressin (AVP) systems is linked to anxiety disorders. Genetic studies in mice reveal CRH system dysfunction contributes to anxiety and depression, suggesting new therapeutic targets.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

NG2-glia: rising stars in stress-related mental disorders?

Molecular psychiatry·2022
Same author

Epigenetic signatures in antidepressant treatment response: a methylome-wide association study in the EMC trial.

Translational psychiatry·2022
Same author

Delineation of molecular pathway activities of the chronic antidepressant treatment response suggests important roles for glutamatergic and ubiquitin-proteasome systems.

Translational psychiatry·2017
Same author

Dioxins, PCBs, chlorinated pesticides and brominated flame retardants in free-range chicken eggs from peri-urban areas in Arusha, Tanzania: Levels and implications for human health.

The Science of the total environment·2016
Same author

SLC6A15, a novel stress vulnerability candidate, modulates anxiety and depressive-like behavior: involvement of the glutamatergic system.

Stress (Amsterdam, Netherlands)·2015
Same author

Deciphering the spatio-temporal expression and stress regulation of Fam107B, the paralog of the resilience-promoting protein DRR1 in the mouse brain.

Neuroscience·2015

Area of Science:

  • Neuroscience
  • Genetics
  • Psychiatry

Background:

  • Anxiety disorders are linked to hyperactivity in central neuropeptidergic systems, specifically corticotropin-releasing hormone (CRH) and vasopressin (AVP) pathways.
  • Chronic stress can perturb these CRH and AVP neurocircuitries, potentially causing abnormal neuronal communication in pathological anxiety.
  • Genetic factors play a significant role in the familial aggregation of anxiety disorders.

Purpose of the Study:

  • To investigate the role of CRH and AVP systems in the etiology and symptomatology of anxiety disorders.
  • To explore how genetic factors influence the CRH system's involvement in anxiety and depression.
  • To identify potential therapeutic strategies by understanding the genetic regulation of CRH-related systems.

Main Methods:

Related Experiment Videos

  • Utilizing refined molecular technologies and genetically engineered mouse models.
  • Specifically targeting individual genes involved in the regulation of CRH peptides, related peptides, receptors, and binding proteins.
  • Analyzing studies performed in genetically modified mice to understand neurocircuitry function.

Main Results:

  • Evidence suggests that chronic stress-induced perturbation of CRH and AVP neurocircuitries contributes to abnormal neuronal communication in anxiety.
  • Studies in genetically engineered mice have provided complementary and extended knowledge on the CRH system's role.
  • Cumulative evidence strongly implicates dysfunction of CRH-related systems in the pathogenesis of anxiety disorders and depression.

Conclusions:

  • Dysfunction of CRH-related systems is implicated in the pathogenesis of anxiety disorders and depression.
  • Genetic studies in mice have elucidated the role of specific genes in CRH system regulation.
  • Findings suggest moving beyond traditional monoaminergic targets for developing novel anxiety and depression therapies.